Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled In Range trial
Battelino T, Danne T, Edelman S, Choudhary P, Renard E et al
Diabetes, obesity and metabolism
https://doi.org/10.1111/dom.14898